 Connection
Zachary Clayton to Antibiotics, Antineoplastic
This is a "connection" page, showing publications Zachary Clayton has written about Antibiotics, Antineoplastic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.729 |
|
|
|
-
Venkatasubramanian R, Mahoney SA, Hutton DA, VanDongen NS, Brunt VE, Greenberg NT, Longtine AG, Brandt L, Beyer AM, Melov S, Rossman MJ, Seals DR, Clayton ZS. Cellular senescence mediates doxorubicin chemotherapy-induced vascular endothelial dysfunction: translational evidence of prevention with senolytic treatment. Am J Physiol Heart Circ Physiol. 2025 12 01; 329(6):H1672-H1683.
Score: 0.858
-
Clayton ZS, Nguyen BL, Venkatasubramanian R, Kabos P. Exercise to Mitigate Premature Vascular Aging After Doxorubicin Breast Cancer Therapy. Exerc Sport Sci Rev. 2025 Oct 01; 53(4):187-194.
Score: 0.852
-
Venkatasubramanian R, Darrah MA, Mahoney SA, Hutton DA, Maurer GS, Ludwig KR, Van Dongen NS, Greenberg NT, Longtine AG, Brunt VE, Singh P, Galligan JJ, Trujillo MN, Kapahi P, Melov S, Rossman MJ, Seals DR, Clayton ZS. Cellular Senescence Mediates Doxorubicin Chemotherapy-Induced Aortic Stiffening: Role of Glycation Stress. Hypertension. 2025 Oct; 82(10):1767-1777.
Score: 0.844
-
Maurer GS, Clayton ZS. Anthracycline chemotherapy, vascular dysfunction and cognitive impairment: burgeoning topics and future directions. Future Cardiol. 2023 09; 19(11):547-566.
Score: 0.175
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|